A test pill Is taken once a day It is useful to help Reduce body weight and reduce blood glucose For patients with type 2 diabetes, according to the new data of the drug rat lily. The drug, also known as the Arborglipron, is a type of drug, which is known as the agonists of the 1 -co -peptide receptors, such as the glucocon (LPG -1), which reflects a hormone, which creates a sense of satisfaction.
But other LPG -1, like Osemic. Lily’s tablet may be the first to get it Win a major barrier The company said in the last phase of medical examination to evaluate the safety and effectiveness of the drug.
The study divided Diabetics The group with type 2: 559 participants was taken by a group of participants, another one took a fictitious pharmaceutical or pill, and was told only to feed and exercise for another group.
At the highest level, the Aforglipron licked body weight The average of 7.9% of the participants, compared to 1.6% of the pharmacies. It has been translated as an average weight loss of 1.3 kg between pill and pharmacies. Drugs too This helped reduce blood glucose. Over time, high blood sugar levels can cause vision problems and damage the nerves of the hands and feet, between other health effects.
The article shows “confident results”
In the words of Lily’s Chairman and CEO David Ricks: “If a comfortable shortened arporglipron made once a day is created and recognized if recognized, Can make it easier to produce Start a large scale to use by people around the world. “
The company said that The other drugs with LPG -1 were equal to the drug. Diarrhea, nausea, indigestion, constipation and vomiting are the most frequent side effects.
No liver problems in the study have not been recorded and it is significant if it is taken into account FyserHe announced that he would leave early this week, It works on a daily shot pill to treat obesity, after a The patient of medical examination Enjoying one Liver sore throat When he stops taking the pill, he will be triggered by the end of the medication.
Independent researchers They have not yet seen all the data, and they are waiting for the release of Lily in a magazine reviewed by experts. But they say the initial results are trusted. “These are important results,” said Cardiometopolic Medical Professor Naveed Sattar in a statement.
“Keep new oral medications that reduce glucose, but weighing significantly, beyond the conditions found with most of the current treatments against diabetes. Type 2 Basic for the future maintenance of diabetes“.
However, Sattar pointed out that it is not yet clear how the new pill usually affects cardiovascular results. Other drugs with LPG -1 have been shown to reduce the risk Heart disease and strokeAmong other things Possible health benefits.
Lily said the article was conducted in the US, China, India, Japan and Mexico Seven advanced phase studies This will assess the performance of the Arbore Cleibran in people with diabetes and obesity.